No abstract available
Keywords:
Cardiorenal; Death; GLP-1 RAs; Network meta-analysis; SGLT2 inhibitors; Type 2 diabetes.
MeSH terms
-
Diabetes Mellitus, Type 2* / complications
-
Diabetes Mellitus, Type 2* / drug therapy
-
Glucagon-Like Peptide 1
-
Glucagon-Like Peptide-1 Receptor
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Network Meta-Analysis
-
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Substances
-
Glucagon-Like Peptide-1 Receptor
-
Hypoglycemic Agents
-
Sodium-Glucose Transporter 2 Inhibitors
-
Glucagon-Like Peptide 1